普洛藥業(yè)隸屬于橫店集團。CDMO為普洛藥業(yè)三大核心業(yè)務之一，致力于為全球制藥公司提供從臨床早期研究直至藥品上市全生命周期所需的醫(yī)藥中間體及原料藥定制研發(fā)生產服務，擁有”合成+發(fā)酵“的雙輪驅動模式，建立流體化學、生物催化以及粉體晶體三大技術平臺。目前公司在橫店、上海、波士頓設立研發(fā)中心，在浙江、山東、安徽等擁有七大生產基地。
Apeloa Pharmaceutical Co., Ltd. belongs to Hengdian group. CDMO is one of Apeloa’s core businesses. CDMO BU is mainly providing contracting, developing and manufacturing service for top pharmaceutical companies in the world on RSM/GMP intermediate/API from early stage to commercial stage. Under the advantage of combining synthesis and fermentation together, flow chemistry，biocatalysis and crystallization platforms have been bulit. ?Apeloa has established R & D center in Hengdian, Shanghai and Boston, and owns 7 production sites located in Zhejiang, Shandong and Anhui, etc.